Priya Varrier’s wink is an answer to saffronists’ protest against Valentine’s Day: Jignesh

Bengaluru, June 23: A senior IAS officer allegedly, who had faced arrest in connection with I Monetary Advice (IMA) scam, today allegedly committed suicide by hanging himself at his residence in the city. 

The deceased is BM Vijay Shankar. He had been arrested by special investigation team (SIT) in the I Monetary Advice (IMA) case when he was deputy commissioner (DC) Urban Bengaluru. 

He had spent few days in the jail over his alleged involvement in the IMA scam and was released on bail. The IMA case is currently being probed by Central Bureau of Investigation.

Shankar was staying in Jayanagar near Ashoka Pillar along with his family members.

Shankar was accused of taking Rs 1.5 crore to approve a report on financial irregularities, and was accused of giving a clean chit to the main accused of IMA scam, Mohammed Mansoor Khan.

The incident came to light around 8 pm. It is alleged that Shankar ended his life around 7.00 pm, when he was alone in the house. Shankar was said to be under severe depression after his name surfaced in the scam, and his subsequent arrest.

However, the exact reason for his extreme step is yet to be identified. Tilak Nagar police have taken up the case of mysterious death under CrPc and are probing further. As of now the police officials have not found any death note. A senior officer said: "once we finish the procedures of investigating the spot his body will be shifted to Victoria hospital for post mortem. The report will find out exact cause of his death".

Police commissioner Bhaskar Rao said: "We have taken up the case of unnatural death with regard to Vijay Shankar's death. Further probe will reveal more details about it".
 

Bengaluru, Mar 21: Central Crime Branch (CCB) sleuths have nabbed a three-member Irani gang, including a woman and recovered from them 1 kg 33 gram stolen gold chains worth about Rs 40 lakh.

City Police Commissioner Bhaskar Rao told newsmen here on Saturday that the arrested were identified as Abujar, Abdul Hussain and Ms. Jenia, all hailed from Bhopal in Madhya Pradesh.

He said that the culprits, who had been arrested on similar theft cases, were out on bail and continued their criminal activities. They were involved in more than 23 cases.

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.